Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
09.02.26
/
50%
€164.40
Target price
09.02.27
-
Performance (%)
-2.31%
Price
09:04
€160.60
Summary
This prediction is currently active. With a performance of -2.31%, the BUY prediction for Biogen Inc. by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 09.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | -2.31% |
| iShares Core DAX® | 1.301% |
| iShares Nasdaq 100 | 0.612% |
| iShares Nikkei 225® | 8.772% |
| iShares S&P 500 | 0.254% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat